[go: up one dir, main page]

AR059296A1 - Compuesto de l-tartrato de s-zopiclona y proceso para resolver los enantiomeros de zopiclona. - Google Patents

Compuesto de l-tartrato de s-zopiclona y proceso para resolver los enantiomeros de zopiclona.

Info

Publication number
AR059296A1
AR059296A1 ARP070100446A ARP070100446A AR059296A1 AR 059296 A1 AR059296 A1 AR 059296A1 AR P070100446 A ARP070100446 A AR P070100446A AR P070100446 A ARP070100446 A AR P070100446A AR 059296 A1 AR059296 A1 AR 059296A1
Authority
AR
Argentina
Prior art keywords
tartrate
zoplicone
zopiclone
tartaric acid
zopiclona
Prior art date
Application number
ARP070100446A
Other languages
English (en)
Inventor
Jie Zhu
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of AR059296A1 publication Critical patent/AR059296A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Un proceso, que comprende hacer reaccionar una mezcla de R- y/o S-zoplicona y/o una sal de los mismos con ácido L-tartárico en un solvente para formar una solucion que contiene iones zopiclona e iones ácido L-tartárico, y a un proceso para incrementar la pureza enantiomérica de S-zoplicona, que comprende: (a) hacer precipitar selectivamente a partir de una solucion, que contiene zoplicona y ácido tartárico como solutos y acetonitrilo como un solvente, un solvato L-tartrato de S- zoplicona acetonitrilo; y (b) tratar dicho solvato L-tartrato de S-zoplicona acetonitrilo con una base de manera de formar S-zoplicona enriquecida, y al uso de ácido L-tartárico en la produccion de S-zoplicona enriquecida y/o de su compuesto L- tartrato. Reivindicacion 1: Un compuesto, caracterizado porque es L-tartrato de S-zopiclona.
ARP070100446A 2006-02-03 2007-02-02 Compuesto de l-tartrato de s-zopiclona y proceso para resolver los enantiomeros de zopiclona. AR059296A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76492706P 2006-02-03 2006-02-03

Publications (1)

Publication Number Publication Date
AR059296A1 true AR059296A1 (es) 2008-03-26

Family

ID=37904886

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070100446A AR059296A1 (es) 2006-02-03 2007-02-02 Compuesto de l-tartrato de s-zopiclona y proceso para resolver los enantiomeros de zopiclona.

Country Status (4)

Country Link
US (1) US20070203145A1 (es)
EP (1) EP1984371A1 (es)
AR (1) AR059296A1 (es)
WO (1) WO2007088073A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2671800B1 (fr) * 1991-01-17 1993-03-12 Rhone Poulenc Rorer Sa Derive de la 5h-pyrrolo[3,4-b]pyrazine optiquement actif, sa preparation et les compositions pharmaceutiques qui le contiennent.
US7476737B2 (en) * 2005-09-05 2009-01-13 Dr. Reddy's Laboratories Limited Eszopiclone process
WO2007109799A2 (en) * 2006-03-23 2007-09-27 Teva Pharmaceutical Industries Ltd. Polymorphs of eszopiclone malate
US20070270590A1 (en) * 2006-04-20 2007-11-22 Marioara Mendelovici Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopiclone
EP1904499A1 (en) * 2006-06-26 2008-04-02 Teva Pharmaceutical Industries Ltd Process for the preparation of zopiclone
US20080287447A1 (en) * 2007-01-31 2008-11-20 Nina Finkelstein Methods for preparing eszopiclone
US20090018336A1 (en) * 2007-06-25 2009-01-15 Nina Finkelstein Racemization process of R-zopiclone
EP2020403A1 (en) 2007-08-02 2009-02-04 Esteve Quimica, S.A. Process for the resolution of zopiclone and intermediate compounds
ES2324136B1 (es) * 2007-10-11 2010-05-31 Apotecnia S.A. Nuevo procedimiento de sintesis y purificacion de (s)-zopiclone cristalino anhidro.
WO2009085988A1 (en) * 2007-12-19 2009-07-09 Sepracor Inc. Salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7- dihydro-5h-pyrrolo[3,4-b]pyrazine
CN101607961B (zh) * 2008-06-18 2011-08-10 天津天士力集团有限公司 一种右佐匹克隆结晶及其组合物
WO2010052475A1 (en) * 2008-11-07 2010-05-14 Cipla Limited Process for resolving zopiclone
CN103193779B (zh) * 2012-01-05 2016-04-20 成都弘达药业有限公司 一种右佐匹克隆的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA04285A (fr) * 1972-01-07 1979-12-31 Rhone Poulenc Sa Nouveaux dérivés de la pyrrolo (3,4-b) pyrazine et leur préparation.
FR2671800B1 (fr) * 1991-01-17 1993-03-12 Rhone Poulenc Rorer Sa Derive de la 5h-pyrrolo[3,4-b]pyrazine optiquement actif, sa preparation et les compositions pharmaceutiques qui le contiennent.

Also Published As

Publication number Publication date
WO2007088073A1 (en) 2007-08-09
EP1984371A1 (en) 2008-10-29
US20070203145A1 (en) 2007-08-30

Similar Documents

Publication Publication Date Title
AR059296A1 (es) Compuesto de l-tartrato de s-zopiclona y proceso para resolver los enantiomeros de zopiclona.
CU23337B7 (es) Resolución de sal quiral
SG170729A1 (en) Processes and intermediates for preparing steric compounds
BRPI0813284A8 (pt) Processo para a preparação de um composto da fórmula (i) e composto
EA201190205A1 (ru) ПОЛЕЗНЫЕ ФАРМАЦЕВТИЧЕСКИЕ СОЛИ 7-[(3R,4R)-3-ГИДРОКСИ-4-ГИДРОКСИМЕТИЛПИРРОЛИДИН-1-ИЛМЕТИЛ]-3,5-ДИГИДРОПИРРОЛО[3,2-d]ПИРИМИДИН-4-ОНА
UY33325A (es) Purificación mediante adsorción de colorante caramelo
BRPI0612957B8 (pt) composto, processos de preparação de compostos, composição farmacêutica e uso de um composto
AR061889A1 (es) Proceso mejorado para la preparacion de voriconazol
ECSP099708A (es) Nuevos métodos
ATE537136T1 (de) Neues verfahren zur herstellung von säurechloriden
MX2010001229A (es) Procedimiento para la resolucion de zopiclona y compuestos intermedios.
BR112015021393A2 (pt) processo para a preparação de (2s,5r)-7-oxo-6-sulfoóxi-2-[(((3r)-piperidina-3-carbonil)-hidrazina carbonil]-1,6-diaza-biciclo[3.2.1]- octano
AR057022A1 (es) Proceso para resolver un r o s acido mandelico a partir de su mezcla racemica
ECSP088319A (es) Síntesis de inhibidores de renina que involucra una reacción de cicloadición
EA201170736A1 (ru) Синтез и новые солевые формы (r)-3-((e)-2-(пирролидин-3-ил)винил)-5-(тетрагидропиран-4-илокси) пиридина
MY148301A (en) Process for the preparation of optically pure or optically enriched enantiomers of sulphoxide compounds
BRPI0606639A2 (pt) novo processo para a preparação de indóis substituìdos
TW200612959A (en) Method for preparing hydroxamic acids
BRPI0516172A (pt) processo para a preparação de 4,5-diidro-pirazol[3,4-c]pirid-2-onas
GB0328871D0 (en) Resolution process
BRPI0616169B8 (pt) cloridrato de lercanidipina na forma polimorfa v, composição farmacêutica compreendendo dito composto e processos para preparação de cloridrato de lercanidipina
AR057555A1 (es) Un inhibidor de fosfodiesterasa-4 4-oxo-1-(3-sustituido fenil-1,4-dihidro-1,8-naftiridin-3-carboxamida y un procedimiento de preparacion del mismo
BRPI0607968A2 (pt) método para preparar um composto de sulfóxido e composto de sulfóxido
CL2008003573A1 (es) Metodo de sintesis enantioselectiva de intermediarios de beta-carbolina del tipo pirrolo-quinolonas por hidrogenacion con auxiliares quirales de cloroformiato.
DE602006014001D1 (de) Herstellung von 2-aminothiazol-5-carbonsäurederivaten

Legal Events

Date Code Title Description
FB Suspension of granting procedure